All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 1, 2023
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

BioWorld MedTech’s Diagnostics Extra for Jan. 30, 2020

Jan. 30, 2020
No Comments
Keeping you up to date on recent developments in diagnostics, including: Increasing early disease detection; Adapting NGS for coronavirus surveillance; AD and HHV: Still a mystery; Increasing accuracy of malaria diagnoses
Read More

WHO declares coronavirus a public health emergency

Jan. 30, 2020
By Michael Fitzhugh
No Comments
The World Health Organization (WHO) has declared a "public health emergency of international concern" over the global outbreak of novel coronavirus (2019-nCoV), reversing a week-ago decision by its International Health Regulations Emergency Committee. The move comes "not because of what is happening in China, but because of what is happening in other countries," said WHO Director General Tedros Adhanom Ghebreyesus, noting his confidence in China’s capacity to control the outbreak. "Our greatest concern is the potential for the virus to spread to countries with weaker health systems, and which are ill-prepared to deal with it," he said.
Read More
Coronavirus test tubes

In China, the race is on to develop, approve test kits for coronavirus

Jan. 30, 2020
By Elise Mak
No Comments
BEIJING – Chinese regulators are speeding up to approve more test kits for the deadly coronavirus that already has killed 170 people and infected more than 7,700 globally. Companies also are working around the clock to develop better products and maintain supplies.
Read More

Regulatory front for Jan. 30, 2020

Jan. 30, 2020
No Comments
The latest global regulatory news, changes and updates affecting medical devices and technologies.
Read More

Other news to note for Jan. 30, 2020

Jan. 30, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaccine, Allergan, Aptinyx, BGI, Biocorrx, Cortexyme, Curetis, Dare, Evotec, Histogen, Inovio, Iteos, Theraly, Tonix.
Read More
Man running up rising arrows

Stryker sees strength in robotics as Mako delivers good news

Jan. 29, 2020
By Liz Hollis
No Comments
Stryker Corp., of Kalamazoo, Mich., saw strength in the fourth quarter, with Mako experiencing good uptake in total knee arthroplasty. Katherine Owen, Stryker’s vice president of strategy & investor relations, said Mako demand was driven by the benefits of its robotic technology, multiple applications and the ability to do cementless knee.
Read More
Chinese flag, Wuhan virus alert button on keyboard

NCoV’s spread is rapid, but so are communications, countermeasures

Jan. 29, 2020
By Nuala Moran
No Comments
LONDON – It has gone from “pneumonia of unknown cause” affecting 44 patients in Wuhan, China, on Jan. 5, 2020, to spark a global health alert, with the World Health Organization (WHO) now looking likely to declare the outbreak of the novel coronavirus, 2019-nCoV, a public health emergency of international concern (PHEIC) less than four weeks later.
Read More
Micrographic image of coronavirus

HHS Secretary: No emergency here … yet

Jan. 29, 2020
By Mari Serebrov
No Comments
Despite pressure from several lawmakers to declare the new coronavirus a U.S. public health emergency, Health and Human Services (HHS) Secretary Alex Azar said such a declaration isn’t needed, at least not yet.
Read More
Coronavirus test tubes

Hong Kong researchers develop coronavirus vaccine

Jan. 29, 2020
By David Ho and Cornelia Zou
No Comments

HONG KONG – As drug developers are racing to find a cure for the new coronavirus, researchers in Hong Kong claim to have made major headway in the development of a vaccine for the virus that has so far killed 132. Yuen Kwok-yung, the chair of infectious diseases at the University of Hong Kong’s (HKU) department of microbiology, said in a press briefing at Hong Kong’s Queen Mary Hospital that his team had successfully isolated the novel virus from the first imported case in Hong Kong. But he said the vaccine still needs months to be tested on animals and an additional year for human trials before it is fit for use.


Read More

Other news to note for Jan. 28, 2020

Jan. 28, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Asahi Kasei, Aska Biotheus, Bravovax, Eyepoint, Genentech, Geovax Labs, Hanx, Inovio, Mundipharma, Ningbo Newbay Medical, Ocumension, Onconova, Otsuka, Paion, Phoremost, Pieris, Taiho, Tilt, Veloxis
Read More
Previous 1 2 … 490 491 492 493 494 495 496 497 498 … 510 511 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 31, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 31, 2023.
  • FDA approved icons and medical professional

    Genmab, Abbvie to join Roche with FDA nod for CD20 bispecific in lymphoma

    BioWorld
    Five months after the first anti-CD20xCD3 T-cell engaging bispecific antibody, Roche Holding AG’s Lunsumio (mosunetuzumab), cleared U.S. FDA approval for...
  • Illustration of pancreas

    Gene therapy to reverse T2D shows proof of concept at ASGCT

    BioWorld
    The most ambitious objective of any treatment is to eradicate the disease, acting on its origin to cure it instead of treating its symptoms. This is the purpose...
  • Clinical data illustration

    Medtronic, Philips, Edwards late-breaking study data spotlighted at EuroPCR

    BioWorld MedTech
    Among the many companies presenting data at the EuroPCR conference in Paris, several late breaking trials from heavy hitters Medtronic plc, Royal Phillips NV and...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing